Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Kefford

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Mutation Research|May 1, 1994
Isolation and preliminary characterisation of an X-ray-sensitive mammalian mutant cell line (WMXRS-1)M J McKay, G J Mann, D A McDonald, et al.
Cancer Research|December 1, 1992
Loss of keratin expression in anaplastic carcinoma cells due to posttranscriptional down-regulation acting in transM L Paine, J R Gibbins, K E Chew, et al.
Oncogene|December 19, 2012
The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanomaJ R Todd, L L Scurr, T M Becker, et al.
The Journal of Biological Chemistry|August 24, 2001
Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARFH Rizos, A P Darmanian, E A Holland, et al.
Oncogene|July 31, 1997
Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutationsH Rizos, T M Becker, E A Holland, et al.
Journal of the National Cancer Institute|September 1, 1993
Unregulated and independent expression of collagenase and transin related to tumor progressionM L Paine, J R Gibbins, J M Whitelock, et al.
Oncogene|May 1, 1994
Loss of heterozygosity and homozygous deletions on 9p21-22 in melanomaE A Holland, S C Beaton, B G Edwards, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1981
Causes of deaths in an oncology unitR F Kefford, N J Cooney, R L Woods, et al.
International Journal of Cancer|March 15, 1989
Amplification of c-ras-Ki oncogene in human ovarian tumoursE M Boltz, R F Kefford, J A Leary, et al.
British Journal of Cancer|July 1, 1990
Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprintingE M Boltz, P Harnett, J Leary, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Mutation Research|May 1, 1994
Isolation and preliminary characterisation of an X-ray-sensitive mammalian mutant cell line (WMXRS-1)M J McKay, G J Mann, D A McDonald, et al.
Cancer Research|December 1, 1992
Loss of keratin expression in anaplastic carcinoma cells due to posttranscriptional down-regulation acting in transM L Paine, J R Gibbins, K E Chew, et al.
Oncogene|December 19, 2012
The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanomaJ R Todd, L L Scurr, T M Becker, et al.
The Journal of Biological Chemistry|August 24, 2001
Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARFH Rizos, A P Darmanian, E A Holland, et al.
Oncogene|July 31, 1997
Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutationsH Rizos, T M Becker, E A Holland, et al.
Journal of the National Cancer Institute|September 1, 1993
Unregulated and independent expression of collagenase and transin related to tumor progressionM L Paine, J R Gibbins, J M Whitelock, et al.
Oncogene|May 1, 1994
Loss of heterozygosity and homozygous deletions on 9p21-22 in melanomaE A Holland, S C Beaton, B G Edwards, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1981
Causes of deaths in an oncology unitR F Kefford, N J Cooney, R L Woods, et al.
International Journal of Cancer|March 15, 1989
Amplification of c-ras-Ki oncogene in human ovarian tumoursE M Boltz, R F Kefford, J A Leary, et al.
British Journal of Cancer|July 1, 1990
Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprintingE M Boltz, P Harnett, J Leary, et al.
Pageof 9